TrialInternational journal of clinical oncology2015

Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined by titration for the treatment of breakthrough pain in Japanese cancer patients: a multicenter, randomized, placebo-controlled, double-blind phase III trial.

Naohito Shimoyama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.